41P - Circulating tumor cells as predictor of response to platinum and pemetrexed chemotherapy in patients with advanced adenocarcinoma of the lung - an u...
|Date||28 March 2014|
|Session||Lunch and poster display session|
|Topics|| Non-Small-Cell Lung Cancer, Metastatic
|Citation||Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131|
F. Grossi1, E. Rijavec1, G. Barletta1, C. Sini1, A. Truini1, A. Alama1, M.G. Dal Bello1, S. Coco1, M. Truini2, C. Genova1
Background: Circulating Tumor Cells (CTC) are cells spread from the primary tumor into the bloodstream; CTC are involved in the development of distant metastases and are associated with aggressive disease.The aim of this study is to evaluate the correlation between the numeric variation of CTC in the blood of patients (pts) with advanced adenocarcinoma (ADK) of the lung during chemotherapy (CHT) and the radiological response to explore their potential role as early predictor of treatment response.